DianneiDNA's Unattributed Round

DianneiDNA raised a round of funding on August 18, 2017. Investors include NNFE.

DianneiDNA (点内生物) is a precision medicine company that has developed an artificial intelligence-powered diagnostic software platform to intelligently screen for lung cancer.…

Articles about DianneiDNA's Unattributed Round: